- Website: http://www.kyowa-kirin.com.cn/
Kyowa Hakko Kirin China Pharmaceutical Co., Ltd., the wholly owned enterprise established in China by Kyowa Hakko Kirin Co., Ltd., is located in the Pudong Zhangjiang Hi-tech Park, with a total investment of 29.8 million dollars. Her predecessor, Kirin KunPeng (China) Bio-Pharmaceutical Co., Ltd., which was founded in June 1997, is the first high-tech bio-medicine program introduced since the establishment of the “National Shanghai Biotech & Pharmaceutical Industrial Base”, and passed the national GMP certification of China. The company was officially changed its name to “Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.” in April 2012.
Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. is an incorporated enterprise having the functions of development, manufacture and marketing, it has a total of more than 220 employees at present, with a basic business scope covering almost the whole Chinese Mainland territory. Currently, the company possesses: recombinant human granulocyte colony-stimulating factor injection, recombinant human erythropoietin injection, cinacalcet hydrochloride tablets, re-packaging right of benidipine hydrochloride tablets and manufacture right of IVD (in vitro diagnosis).
Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. is a company integrating pharmaceutical development, production and sales, playing an important role in the globalization of Kyowa Hakko Kirin Co., Ltd. (headquartered in Japan). It is currently engaged in the core fields of Nephrology and Oncology, with featured products such as GRAN, ESPO and REGPARA.
653 total views, 2 today
- Distinguishing males from females among king penguins
- Low-fat or low-carb? It's a draw, study finds
- Medical News Today: Osteoarthritis: Could researchers have found the key to prevention?
- Resolving Interfacial Protein Dynamics by STReM
- Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in Rhode Island
- Canadian stroke victims at higher risk of dying in rural hospitals
- Medical News Today: What should you not eat for IBS?
- Study helps explain why people feel hungrier after weight loss
- Outdoor instruction makes students more open to learning
- Factors identified that impact physicians IT adoption